List of Top 5 Pharma Stocks in India of 2022

Sun Pharmaceutical Industries

Sun Pharmaceutical Industries Ltd is the largest pharma company of India is engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulations and Active Pharma Ingredients.

Sun Pharmaceutical Industries

Company have a healthy dividend payout of 53.6% but delivered a poor sales growth of 4.13% over past five years. Also low return on equity of 11.5% for last 3 years. – Symbol : SUNPHARMA – Market Cap : ₹ 211,393 Cr. – Current Price : ₹ 881 – High / Low : ₹ 967 / 734 – Debt : ₹ 1,290 Cr.

Zydus Lifesciences Ltd

Zydus Lifesciences Ltd. is One of the top five pharmaceutical companies in India since 1995, the group was restructured and thus was formed Cadila Healthcare under the aegis of the Zydus group.

Zydus Lifesciences Ltd

 Group witnessed a significant financial growth and registered a turnover of over Rs. 14,253 crores in FY20. Maintaining a healthy dividend payout of 17.6% but delivered a poor sales growth of 10.2% over past 5 years. – Symbol : ZYDUSLIFE – Market Cap : ₹ 40,120 Cr. – Current Price : ₹ 392 – High / Low : ₹ 573 / 319 – Debt : ₹ 4,221 Cr.

Dr. Reddy's Laboratories

Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company started in 1984. The company has over 190 medications, 60 active pharmaceutical ingredients (APIs) for drug manufacturer.

Dr. Reddy's Laboratories

Top revenue contributors of the segment are nervous system drugs (14%), gastrointestinal (13%) & anti-infective (10%).  Company has been maintaining a healthy dividend payout of 21.6% but delivered a poor sales growth of 8.70% inpast 5 years. – Symbol: DRREDDY – Market Cap : ₹ 70,294 Cr. – Current Price  : ₹ 4,223 – High / Low : ₹ 5,079 / 3,654 – Debt : ₹ 3,384 Cr.

Cipla Limited

Cipla Limited is an Indian multinational pharmaceutical company founded by Khwaja Abdul Hamied in 1984. On 17 September 2014, its market capitalisation was ₹49,611.58 crore and in 2020 its reaches to 1 Billion. It is the third largest Pharamceutical company in India.

Cipla Limited

Cipla is present in 170 countries and most of its revenue comes from India 40%, Africa, and the US 21%. Delivered good profit growth of 23.1% CAGR over last 5 years and maintaining a healthy dividend payout of 17.9% but low return on equity of 12.2% for last 3 years. – Symbol : CIPLA – Market Cap: ₹ 83,617 Cr. – Current Price : ₹ 1,036 – High / Low : ₹ 1,083 / 850 – Debt : ₹ 1,056 Cr.

Biocon Ltd

Biocon Ltd  is among the world’s Top 15 bio-manufacturing companies founded by Kiran Mazumdar-Shaw in 1978. It is the Only Indian company to get FDA approval for 3 biosimilar molecules (Trastuzumab, Pegfilgrastim, and Insulin Glargine).

Biocon Ltd

Dividend payout has been low at 3.09% of profits over last 3 years along with company has a low return on equity of 9.92% for last 3 years. – Symbol : BIOCON – Market Cap : ₹ 36,804 Cr. – Current Price : ₹ 307 – High / Low : ₹ 411 / 303 – Debt : ₹ 5,147 Cr.